Albumin Excipient Market Expected to Achieve 6.8% CAGR by 2029: Growth Forecast Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Albumin Excipient Market Size By 2025?
The market size of albumin excipient has experienced significant growth recently. It is projected to develop from $4.85 billion in 2024 to $5.2 billion in 2025, with a compound annual growth rate (CAGR) of 7.1%. Factors such as expansion in the biopharmaceutical industry, broader adoption of biologics, increased occurrence of chronic diseases, clinical progression, drug innovation, and a heightened emphasis on drug delivery have all contributed to the growth in the historical period.

How Big Is the Albumin Excipient Market Size Expected to Grow by 2029?
Expectations are high for a robust expansion in the albumin excipient market within the coming years, with projections anticipating a growth rate of 6.8% leading to a market value of $6.77 billion by 2029. This positive projection for the forecast period is believed to be driven by multiple factors, such as the persistent expansion in the biopharmaceutical industry, a growing pipeline for biologics, an increasing global geriatric demographic, worldwide initiatives for vaccination, and escalating investments in drug development. Notable trends foreseen during this forecast period include an emphasis on biodegradable and biocompatible attributes, cooperative partnerships and collaboration in research, adherence to regulatory compliance and quality benchmarks, the use of albumin in cell therapy, and a surge in customized and tailored solutions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/albumin-excipient-global-market-report

Which Key Market Drivers Powering Albumin Excipient Market Expansion and Growth?
The growth of the albumin excipient market is predicted to surge due to the increasing incidence of chronic illnesses. Chronic ailments, which last more than three months and have the potential to worsen over time, use albumin in their treatment. Notably, albumin serves as a blood volumizer and is the most plentiful circulating protein in plasma. It acts as a flexible protein carrier for drug targeting and enhances the pharmacokinetic profile of peptide or protein-based medications used in managing various diseases such as cancer and diabetes. For example, projections from the World Health Organization, a United Nations agency based in Switzerland, stated in February 2024 that by 2050, cancer cases would exceed 35 million, reflecting a 77% rise in comparison to the predicted 20 million cases in 2022. Thus, the escalating incidence of chronic diseases is a considerable driver for the growth of the albumin excipient market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10672&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Albumin Excipient Market?
Leading corporations in the albumin excipient market are shifting towards strategic alliances to bolster essential sectors like biotechnology and pharmaceuticals. The concept of strategic alliances means corporations augment each other's strengths and resources to obtain benefits and marks of success reciprocally. For example, in October 2023, ARTES Biotechnology GmbH, a biotech firm based in Germany, joined forces with Basic Pharma, a pharmaceutical company based in the Netherlands, to boost recombinant protein production. With this collaboration, their objective is to propel the advancement of pharmaceutical recombinant protein production by enhancing supply chain efficiency and shortening the new product time-to-market.

What Are the Emerging Segments in the Albumin Excipient Market?
The albumin excipient market covered in this report is segmented -

1) By Product: Human Serum Albumin, Recombinant Albumin
2) By End-Users: Pharmaceutical And Biotechnology Industry, Research Institutes, Other End Users

Subsegments:
1) By Human Serum Albumin: 5% Human Serum Albumin, 20% Human Serum Albumin
2) By Recombinant Albumin: Recombinant Human Serum Albumin, Recombinant Bovine Serum Albumin

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10672&type=smp

Who Are the Global Leaders in the Albumin Excipient Market?
Major companies operating in the albumin excipient market include Albumin Therapeutics LLC, Biotest AG, CSL Behring,Grifols S.A., HiMedia Laboratories LLC, InVitria Inc., Medxbio Pte Ltd., Octapharma AG, RayBiotech Inc., SeraCare Life Sciences Inc., Sigma-Aldrich Pty. Ltd., Hualan Biological Engineering Inc., Kedrion Biopharma, LFB USA Inc., Shanghai RAAS Blood Products Co. Ltd., Baxter International Inc., Merck KGaA, Thermo Fisher Scientific Inc., Albumedix A/S, Bio Products Laboratory Ltd., Shire Plc., Ventria Bioscience Inc., Novartis AG, China Biologic Products Holdings Inc., ProMetic Life Sciences Inc., Sanquin, Biopharma, Takeda Pharmaceutical Company Limited, FUJIFILM Irvine Scientific Inc.

Which are the Top Profitable Regional Markets for the Albumin Excipient Industry?
North America was the largest region in the Albumin Excipient market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global albumin excipient market report during the forecast period. The regions covered in the albumin excipient market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10672

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.